TREM2 activation by APOE induces significant changes in microglia gene expression and in models of neurodegenerative diseases, such as APP-PS1 mice (a model for AD); the activation of this signaling pathway is associated with increased amyloid plaque pathology. Here, TREM2 is linked to Alzheimer disease.